Learning objectives:

1) Discuss problems related to establishing ERAS protocols in patients with end stage liver disease. 2) Create a management plan for diagnosis and treatment of infections in the immunosuppressed patient. 3) Consolidate modern knowledge regarding application of ECMO in patients with  end stage liver disease undergoing liver transplantation. 4) Recognize risks and benefits associated with early vs. late initiation of renal replacement therapy.   Dmitri Bezinover (United States) Marina Moguilevitch (United States)   Click here to view this session in the congress program.